Exact Mass: 319.0546

Exact Mass Matches: 319.0546

Found 233 metabolites which its exact mass value is equals to given mass value 319.0546, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

C01285

4-(3,5-Dichloro-4-hydroxyphenylimino)tetralin-1-one

C16H11Cl2NO2 (319.0167)

Tetrodotoxin

(1R,5R,6R,7R,9S,11R,12R,13S,14S)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1(7,11).0(1,6)]tetradecane-5,9,12,13,14-pentol

C11H17N3O8 (319.1016)

A quinazoline alkaloid that is a marine toxin isolated from fish such as puffer fish. It has been shown to exhibit potential neutotoxicity due to its ability to block voltage-gated sodium channels. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Tetrodotoxin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=4368-28-9 (retrieved 2024-09-06) (CAS RN: 4368-28-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

RO19-4603

Ro 19-4603

C15H17N3O3S (319.0991)

Benzamil

3,5-diamino-N-(N-benzylcarbamimidoyl)-6-chloropyrazine-2-carboxamide

C13H14ClN7O (319.0948)

ci no 52015

Methylthioninium Chloride

C16H18ClN3S (319.091)

V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AB - Antidotes V - Various > V04 - Diagnostic agents > V04C - Other diagnostic agents > V04CG - Tests for gastric secretion COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Ibandronate

{1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl}phosphonic acid

C9H23NO7P2 (319.095)

Ibandronate is a nitrogen-containing bisphosphonate in the same class as alendronate and risedronate. Ibandronate inhibits osteoclast-mediated bone resorption. All of the bisphosphonates prevent the breakdown of bone by bone cells called osteoclasts. In persons who are at high risk for osteoporosis, bisphosphonates not only result in increased amounts of bone and bone strength, they also reduce the risk of hip fractures and other bone fractures. M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates

N-Gluconyl ethanolamine phosphate

(2R,3S,4S,5R)-2,3,4,5,6-Pentahydroxy-N-[2-(phosphonooxy)ethyl]hexanimidate

C8H18NO10P (319.0668)

N-Gluconyl ethanolamine phosphate is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]")

N-(p-Toluenesulfonyl)-L-phenylalanine

2-(4-methylbenzenesulfonamido)-3-phenylpropanoic acid

C16H17NO4S (319.0878)

ONO-2235; ONO 2235; ONO2235; Sorbistat

2-[5-(2-methyl-3-phenylprop-2-en-1-ylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid

C15H13NO3S2 (319.0337)

5,9:7,10a-Dimethano-10aH-[1,3]dioxocino[6,5-d]pyrimidine-4,7,10,11,12-pentol, octahydro-12-(hydroxymethyl)-2-imino-,(4R,4aR,5R,7S,9S,10S,10aR,11S,12S)-

C11H17N3O8 (319.1016)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D049990 - Membrane Transport Modulators

2-Chloro-N-[(Z)-[3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl]methylideneamino]benzamide

2-Chloro-N-{[3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl]methylidene}benzene-1-carbohydrazonate

C15H14ClN3O3 (319.0724)

Sarmazenil

ethyl 11-chloro-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,11,13-pentaene-5-carboxylate

C15H14ClN3O3 (319.0724)

6-Hydroxydelphinidin

3,5,6,7-Tetrahydroxy-2-(3,4,5-trihydroxyphenyl)-flavylium

C15H11O8 (319.0454)

CHEMBL451964

C15H12F3N5 (319.1045)

Maybridge1_008899

C12H12F3N3O2S (319.0602)

ZINC4324866

C12H15Cl2N3O3 (319.049)

Maybridge1_005917

C15H14ClN3OS (319.0546)

2-(tert-Butylsulfonyl)-3-(3-methylbenzo[b]thiophen-2-yl)acrylonitrile

C16H17NO2S2 (319.0701)

SCHEMBL12230664

C14H13N3O4S (319.0627)

2-(1,3-benzoxazol-2-ylsulfanyl)-N-(1,3-thiazol-2-yl)butanamide

C14H13N3O2S2 (319.0449)

CHEMBL3637844

C17H18ClNO3 (319.0975)

DTXSID50954382

C11H17N3O8 (319.1016)

Decarine

[1,3]Benzodioxolo[5,6-c]phenanthridin-2-ol, 1-methoxy-

C19H13NO4 (319.0845)

A natural product found particularly in Zanthoxylum caudatum and Zanthoxylum viride.

brevianamide N

C18H13N3O3 (319.0957)

Hernandonine

C18H9NO5 (319.0481)

An oxoaporphine alkaloid isolated from Hernandia ovigera and Lindera chunii and has been shown exhibit inhibitory activity against HIV-1 integrase .

(7R,8S)-7,8-dihydroxyrutaecarpine

C18H13N3O3 (319.0957)

SCHEMBL13886471

C11H17N3O8 (319.1016)

Norisoterihanin

C19H13NO4 (319.0845)

Usutalic imide

C19H13NO4 (319.0845)

1,2-Dihydroxyrutaecarpine

C18H13N3O3 (319.0957)

CHEMBL3182641

C15H13NO3S2 (319.0337)

2-(3,4-dihydro-2-methoxy-4-oxoquinazolinyl)-1H-indole-3-carboxaldehyde|orirenierine B

C18H13N3O3 (319.0957)

Cassameridine

C18H9NO5 (319.0481)

An oxoaporphine alkaloid that is 7H-dibenzo[de,g]quinolin-7-one which is substituted by methylenedioxy grups at the 1,2 and 9,10 positions. Compared with liriodenine, which lacks the 9,10-methylenedioxy group, cassameridine displays only moderate antifungal activity.

CHEMBL3597759

C19H13NO4 (319.0845)

Ala Asp Asp

C11H17N3O8 (319.1016)

Gly Asp Glu

C11H17N3O8 (319.1016)

Gly Glu Asp

C11H17N3O8 (319.1016)

Asp Ala Asp

C11H17N3O8 (319.1016)

Asp Asp Ala

C11H17N3O8 (319.1016)

Epalrestat

C15H13NO3S2 (319.0337)

C471 - Enzyme Inhibitor > C72880 - Aldose Reductase Inhibitor D004791 - Enzyme Inhibitors

MMV676383

C14H13N3O2S2 (319.0449)

MMV202458

C17H18NO3Cl (319.0975)

1,N2-6-Oxo-malondialdehyde-deoxyguanosine

C13H13N5O5 (319.0917)

Asp Gly Glu

C11H17N3O8 (319.1016)

Glu Gly Asp

C11H17N3O8 (319.1016)

Glu Asp Gly

C11H17N3O8 (319.1016)

Asp Glu Gly

C11H17N3O8 (319.1016)

Ibandronate

Ibandronate sodium;Ibandronate sodium monohydrate;Ibandronic Acid;R484

C9H23NO7P2 (319.095)

M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates

N-Gluconyl ethanolamine phosphate

{2-[(2R,3S,4S,5R)-2,3,4,5,6-pentahydroxyhexanamido]ethoxy}phosphonic acid

C8H18NO10P (319.0668)

3-[[2-(4-chloro-3-methylphenoxy)acetyl]amino]benzoic acid

C16H14ClNO4 (319.0611)

Cetophenicol

Acetamide,N-[(1R,2R)-2-(4-acetylphenyl)-2-hydroxy-1-(hydroxymethyl)ethyl]-2,2-dichloro-

C13H15Cl2NO4 (319.0378)

C254 - Anti-Infective Agent > C52588 - Antibacterial Agent

N-BOC-2-(3-TRIFLUOROMETHYLPHENYL)-DL-GLYCINE

C14H16F3NO4 (319.1031)

N-Boc-2-(4-trifluoromethylphenyl)-DL-glycine

C14H16F3NO4 (319.1031)

3-bromo-4-[(4-methylphenyl)methylamino]benzoic acid

C15H14BrNO2 (319.0208)

Methyl 5,5,5-trifluoro-4-(2-(4-nitrophenyl) hydrazono)pentanoate

C12H12F3N3O4 (319.078)

1-(PHENYLSULFONYL)-1H-INDOLE-2-CARBONYL CHLORIDE

C15H10ClNO3S (319.007)

(S)-(+)-Norepinephrine L-bitartrate

C12H17NO9 (319.0903)

METHYL 2-((TERT-BUTOXYCARBONYL)AMINO)-5-(TRIFLUOROMETHYL)BENZOATE

C14H16F3NO4 (319.1031)

boc-l-2,4,5-trifluorophe

C14H16F3NO4 (319.1031)

3-[4-(METHOXYCARBONYL)PHENYL]-3-[(2,2,2-TRIFLUOROACETYL)AMINO]PROPANOIC ACID

C13H12F3NO5 (319.0668)

(r)-phenyl-(toluene-4-sulfonylamino)-acetic acid methyl ester

C16H17NO4S (319.0878)

1-(3-Bromo-5-methylpyridin-2-yl)-4-ethylpiperazine hydrochloride

C12H19BrClN3 (319.0451)

4-bromo-2-ethoxy-N-phenylbenzamide

C15H14BrNO2 (319.0208)

methyl 3-[(2,4-dimethylphenyl)sulfonylamino]benzoate

C16H17NO4S (319.0878)

METHYL 2-(4-METHYLPHENYLSULFONAMIDO)-2-PHENYLACETATE

C16H17NO4S (319.0878)

2-methyl-3-sulfobutyl-5-chlorobenzothiazolium, inner salt

C12H14ClNO3S2 (319.0104)

2-nitrobenzaldehyde tosylhydrazone

C14H13N3O4S (319.0627)

(R)-2-(4-Methylphenylsulfonamido)-3-phenylpropanoicacid

C16H17NO4S (319.0878)

METHYL 4-(ETHYLCARBAMOYL)-2,3-DIFLUORO-[1,1-BIPHENYL]-3-CARBOXYLATE

C17H15F2NO3 (319.102)

Norepinephrine Bitartrate

C12H17NO9 (319.0903)

6,7-Difluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid

C16H8F3NO3 (319.0456)

2-amino-2-(3,4-dichlorophenyl)-3-[(2-methylpropan-2-yl)oxy]-3-oxopropanoic acid

C13H15Cl2NO4 (319.0378)

METHYL2-(PIPERIDIN-4-YLSULFONYL)BENZOATEHYDROCHLORIDE

C13H18ClNO4S (319.0645)

Bupropion hydrobromide

C13H19BrClNO (319.0338)

C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

4-(4-chloro-2-fluoroanilino)-6-methoxy-1H-quinazolin-7-one

C15H11ClFN3O2 (319.0524)

1-Azulenesulfonic acid, 3,8-dimethyl-5-(1-methylethyl)-, sodium salt, hydrate (2:2:1)

C15H20NaO4S (319.098)

3-amino-6-phenyl-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carbonitrile

C15H8F3N3S (319.0391)

CNP-AFU

C12H14ClNO7 (319.0459)

2-[2-(4-morpholin-4-ylanilino)-1,3-thiazol-4-yl]acetic acid

C15H17N3O3S (319.0991)

N-Benzyl-N,N-diethylethanaminium iodide

C13H22IN (319.0797)

Diphenylammonium trifluoromethanesulfonate

C13H12F3NO3S (319.049)

N-(2,3-Dihydro-2-oxo-1H-benzimidazol-5-yl)-3-hydroxy-2-naphthalenecarboxamide

C18H13N3O3 (319.0957)

4-(6-METHOXY-2-NAPHTHYL)-6-(TRIFLUOROMETHYL)PYRIMIDIN-2-AMINE

C16H12F3N3O (319.0932)

Neodymium tri(2-propanolate)

C9H21NdO3 (319.0568)

5-BROMO-3-(2-PYRIDIN-2-YL-PYRROLIDIN-1-YL)-PYRAZIN-2-YLAMINE

C13H14BrN5 (319.0433)

5-BROMO-3-(2-PYRIDIN-3-YL-PYRROLIDIN-1-YL)-PYRAZIN-2-YLAMINE

C13H14BrN5 (319.0433)

2-Chloroadenosine hemidydrate

C10H14ClN5O5 (319.0683)

Ro 19-4603

Tert-butyl 5-methyl-6-oxo-5,6-dihydro-4h-imidazo[1,5-a]thieno[2,3-f][1,4]diazepine-3-carboxylate

C15H17N3O3S (319.0991)

boc-d-3,4,5-trifluorophenylalanine

C14H16F3NO4 (319.1031)

(1R,2S)-2-(3,4-DIFLUOROPHENYL)CYCLOPROPANAMINE (2R,3R)-2,3-DIHYDROXYSUCCINATE

C13H15F2NO6 (319.0867)

3-FLUORO-5-(5-((2-METHYLTHIAZOL-4-YL)ETHYNYL)PYRIDIN-2-YL)BENZONITRILE

C18H10FN3S (319.0579)

7-(1,3-Benzothiazol-2-yl)-6-hydroxy-4-oxo-1,4-dihydro-3-quinoline carbonitrile

C17H9N3O2S (319.0415)

5-[3,5-Bis(trifluoromethyl)phenyl]-3-pyridinecarbaldehyde

C14H7F6NO (319.0432)

N-[5-Acetyl-2-(benzyloxy)phenyl]methanesulfonamide

C16H17NO4S (319.0878)

tert-Butyl (3-iodophenyl)carbamate

C11H14INO2 (319.0069)

N-(4-Chlorobenzoyloxy)-4-nitrobenzimidamide

[[Amino-(4-nitrophenyl)methylidene]amino] 4-chlorobenzoate

C14H10ClN3O4 (319.036)

2-Bromo-N,N-dipropylbenzenesulfonamide

C12H18BrNO2S (319.0242)

(R)-ethyl 2-(1-(benzyloxycarbonyl)ethyl)thiazole-5-carboxylate

C16H17NO4S (319.0878)

N-(2-(4-BROMOPHENYL)PROPYL)PROPANE-2-SULFONAMIDE

C12H18BrNO2S (319.0242)

4-Chloro-6-(trifluoromethoxy)quinoline-3-carboxylic acid ethyl ester

C13H9ClF3NO3 (319.0223)

1-(3-Bromophenyl)-2-[(2-methyl-2-propanyl)amino]-1-propanone hydr ochloride (1:1)

C13H19BrClNO (319.0338)

Fenamiphos metabolite

C13H22NO4PS (319.1007)

METHYL 2-([(4-CHLOROPHENYL)SULFONYL]AMINO)-4-METHYLPENTANOATE

C13H18ClNO4S (319.0645)

METHYL 2-((ISOPROPOXYCARBONYL)AMINO)-5-METHYL-4-(TRIFLUOROMETHYL)BENZOATE

C14H16F3NO4 (319.1031)

[(1R)-1-(benzyloxycarbonylamino)-2-phenyl-ethyl]phosphinic acid

C16H18NO4P (319.0973)

Methyl 2-amino-5-iodo-4-isopropylbenzoate

C11H14INO2 (319.0069)

Sarmazenil

C15H14ClN3O3 (319.0724)

C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

Noradrenaline tartrate

C12H17NO9 (319.0903)

ETHYL 5-HYDROXY-2-(METHYLTHIO)-7-OXO-8-(PROP-2-YNYL)-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXYLATE

C14H13N3O4S (319.0627)

TRANS-3-CHLORO-4-BENZYLOXY-5-METHOXY-BE&

C16H14ClNO4 (319.0611)

TRANS-2-CHLORO-3-BENZYLOXY-4-METHOXY-BE&

C16H14ClNO4 (319.0611)

tert-butyl (4-iodophenyl)carbamate

C11H14INO2 (319.0069)

1-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dimethylmethanamine

C16H15Cl2N3 (319.0643)

4-(6-Bromo-4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)-2-pyrimidinamine

C12H10BrN5O (319.0069)

tert-butyl 2-amino-5-iodobenzoate

C11H14INO2 (319.0069)

Ethyl 4-(dimethylamino)-3-iodobenzoate

C11H14INO2 (319.0069)

Methyl 2-(benzylamino)-5-bromobenzoate

C15H14BrNO2 (319.0208)

Thiazolidine, 2-(4-methylphenyl)-3-(phenylsulfonyl)- (9CI)

C16H17NO2S2 (319.0701)

N-p-Tosyl-L-phenylalanine

C16H17NO4S (319.0878)

METHYL N-P-TOLUENESULFONYL-L-2-PHENYLGLYCINATE

C16H17NO4S (319.0878)

TRIAMMINETUNGSTEN(IV) TRICARBONYL

C3H9N3O3W (319.0153)

3-(5,6-dichloro-1-methylindol-2-yl)benzoic acid

C16H11Cl2NO2 (319.0167)

boc-d-2,4,5-trifluorophe

C14H16F3NO4 (319.1031)

1-(benzenesulfonyl)indole-3-carbonyl chloride

C15H10ClNO3S (319.007)

n-(2-(4-bromophenoxy)ethyl)piperidine hydrochloride

C13H19BrClNO (319.0338)

2-Methyl-2-propanyl (2-iodophenyl)carbamate

C11H14INO2 (319.0069)

Febuxostat impurity 8

C16H17NO4S (319.0878)

4-(3-Chloro-2-fluoroanilino)-6-hydroxy-7- methoxyquinazoline

C15H11ClFN3O2 (319.0524)

4-(chloromethyl)-2-(4-ethoxy-3-methoxyphenyl)-1,3-thiazole hydrochloride

C13H15Cl2NO2S (319.0201)

9,10 - dimethylacridinium methyl sulfate

C16H17NO4S (319.0878)

OCTYL RESIN

C13H9N3O7 (319.044)

N-Cbz-S-2-Chlorophenylglycine

C16H14ClNO4 (319.0611)

N-(4-Bromobenzyl)-4-Methoxybenzamide

C15H14BrNO2 (319.0208)

1-Oxa-8-azaspiro[4,5]decane-8-carboxylic acid,3-bromo-,1,1-dimethylethylester

C13H22BrNO3 (319.0783)

Benzyl (4-bromo-2-methylphenyl)carbamate

C15H14BrNO2 (319.0208)

FAAH-IN-2

4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ol

C15H11ClFN3O2 (319.0524)

FAAH-IN-2 (O-Desmorpholinopropyl Gefitinib) is a potent FAAH(fatty acid amide hydrolase) inhibitor extracted from Patent WO/2008/100977A2.

2-Bromo-N-hexylbenzenesulfonamide

C12H18BrNO2S (319.0242)

tert-Butyl 5-chloro-6-(trifluoromethyl)-1H-indole-1-carboxylate

C14H13ClF3NO2 (319.0587)

(3-Fluoro-4-(((4-methoxybenzyl)oxy)carbamoyl)phenyl)boronic acid

C15H15BFNO5 (319.1027)

N-(4-BROMOPHENYL-N-(4-CARBETHOXYPHENYL)AMINE

C15H14BrNO2 (319.0208)

Flumazenil Impurity F

C15H14ClN3O3 (319.0724)

6-Chloro-2-(4-chlorophenyl)imidazo[1,2-α]pyridine-3-acetamide

C15H11Cl2N3O (319.0279)

7-Chloro Epinastine Hydrochloride

C16H15Cl2N3 (319.0643)

(Trimethyl)methylcyclopentadienylplatinum(IV)

C9H16Pt (319.09)

Norepinephrine tartrate

C12H17NO9 (319.0903)

2-[benzyl-(4-methylphenyl)sulfonyl-amino]acetic acid

C16H17NO4S (319.0878)

boc-l-3,4,5-trifluorophenylalanine

C14H16F3NO4 (319.1031)

methyl 5-iodo-2-(propan-2-ylamino)benzoate

C11H14INO2 (319.0069)

4-(Diethylamino)-3-iodobenzoic acid

C11H14INO2 (319.0069)

3-iodo-4-(2-methylpropylamino)benzoic acid

C11H14INO2 (319.0069)

(1R)-1-(2-Thienylacetylamino)-1-(3-carboxyphenyl)methylboronic acid

C14H14BNO5S (319.0686)

2-([(4-Methylphenyl)sulfonyl]amino)-3-phenylpropanoic acid

C16H17NO4S (319.0878)

2-[(5Z)-5-[(Z)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid

C15H13NO3S2 (319.0337)

2-Acetylaminofluorene-N-sulfate

C15H13NO5S (319.0514)

6,11-Dioxo-12-naphtho[2,3-b]indolizinecarboxylic acid ethyl ester

C19H13NO4 (319.0845)

2-Hydroxy-4-methylbenzoic acid [2-(2-chloroanilino)-2-oxoethyl] ester

C16H14ClNO4 (319.0611)

Glutamyl-aspartyl-glycine

C11H17N3O8 (319.1016)

4-fluoro-N-(4-fluoro-1,3-benzothiazol-2-yl)-1,3-benzothiazol-2-amine

C14H7F2N3S2 (319.0049)

N-(6-phenyl-5-imidazo[2,1-b]thiazolyl)benzamide

C18H13N3OS (319.0779)

N-(4-methyl-2-thiazolyl)-3-(2-oxo-1,3-benzothiazol-3-yl)propanamide

C14H13N3O2S2 (319.0449)

Benzene, 1,2,3,4,5-pentafluoro-6-((4-nitrophenoxy)methyl)-

C13H6F5NO3 (319.0268)

(11R,13S)-3-amino-5,12,13,14-tetrahydroxy-14-(hydroxymethyl)-8,10-dioxa-2-aza-4-azoniatetracyclo[7.3.1.17,11.01,6]tetradec-3-en-9-olate

C11H17N3O8 (319.1016)

ibandronic acid

C9H23NO7P2 (319.095)

4-Coumaroylshikimate anion

C16H15O7- (319.0818)

5-Methyldeoxycytidine 5-phosphate

C10H14N3O7P-2 (319.0569)

3,4,8,9,10-Pentahydroxy-6-oxobenzo[c]chromene-1-carboxylate

C14H7O9- (319.009)

-[(1R,3S)-5,6,9,10-tetrahydroxy-1-methyl-1H,3H,4H-naphtho[2,3-c]pyran-3-yl]acetate

C16H15O7- (319.0818)

(2R,3R)-3,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-2,3-dihydrochromen-5-olate

C15H11O8- (319.0454)

2-Chloro-N-[(Z)-[3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl]methylideneamino]benzamide

C15H14ClN3O3 (319.0724)

(11S,13S)-3-Amino-5,12,13,14-tetrahydroxy-14-(hydroxymethyl)-8,10-dioxa-2-aza-4-azoniatetracyclo[7.3.1.17,11.01,6]tetradec-3-en-9-olate

C11H17N3O8 (319.1016)

4-chloro-N-[2-(4-nitroanilino)ethyl]benzamide

C15H14ClN3O3 (319.0724)

N-[[[(4-methoxyphenyl)-oxomethyl]hydrazo]-sulfanylidenemethyl]-2-furancarboxamide

C14H13N3O4S (319.0627)

N-[4-[[acetamido(sulfanylidene)methyl]amino]phenyl]-2-thiophenecarboxamide

C14H13N3O2S2 (319.0449)

6-Ethoxy-2-[(4-fluorophenyl)methylthio]-1,3-benzothiazole

C16H14FNOS2 (319.0501)

1-(4-Ethyl-2-pyridinyl)-3-(4-methylphenyl)sulfonylurea

C15H17N3O3S (319.0991)

N-[(1,3-dimethyl-4,6-dioxo-2-thioxotetrahydropyrimidin-5(2H)-ylidene)methyl]pyridine-4-carbohydrazide

C13H13N5O3S (319.0739)

Asp-Gly-Glu

C11H17N3O8 (319.1016)

Asp-Ala-Asp

C11H17N3O8 (319.1016)

Asp-Glu-Gly

C11H17N3O8 (319.1016)

3-[[(3-Chloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acid

C16H14ClNO4 (319.0611)

[3-(4-Chlorophenyl)-5-(methylthio)-1,2,4-triazol-1-yl]-(2-furanyl)methanone

C14H10ClN3O2S (319.0182)

(4-Bromo-2,5-dimethyl-3-pyrazolyl)-(2,3-dihydroindol-1-yl)methanone

C14H14BrN3O (319.032)

N-(1,3-benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidinamine

C18H13N3O3 (319.0957)

1-(2-Methylprop-2-enyl)-3-[(5-nitro-2-oxo-3-indolyl)amino]thiourea

C13H13N5O3S (319.0739)

2-(4-Chlorophenyl)-4-(ethylthio)-6-(1-pyrrolidinyl)pyrimidine

C16H18ClN3S (319.091)

N-[2-[(2-chloro-1-oxopropyl)hydrazo]-2-oxoethyl]benzenesulfonamide

C11H14ClN3O4S (319.0394)

6,7-dimethoxy-2-[(1H-1,2,4-triazol-5-ylthio)methyl]-1H-quinazolin-4-one

C13H13N5O3S (319.0739)

N-(1-cyano-3-pyrrolidinyl)-4-(trifluoromethyl)benzenesulfonamide

C12H12F3N3O2S (319.0602)

(E)-3-(5-bromofuran-2-yl)-N-[(4-methylphenyl)methyl]prop-2-enamide

C15H14BrNO2 (319.0208)

1-[[2-(3,4-Dichlorophenyl)acetyl]amino]-3-propylthiourea

C12H15Cl2N3OS (319.0313)

5-Methoxyaminomethyl-2-thiouridine

C11H17N3O6S (319.0838)

Ala-Asp-Asp

C11H17N3O8 (319.1016)

Gly-Asp-Glu

C11H17N3O8 (319.1016)

Gly-Glu-Asp

C11H17N3O8 (319.1016)

Glu-Gly-Asp

C11H17N3O8 (319.1016)

Asp-Asp-Ala

C11H17N3O8 (319.1016)

Aspartyl-glycyl-glutamic acid

C11H17N3O8 (319.1016)

(11S,13S)-3-amino-14-(hydroxymethyl)-8,10-dioxa-2,4-diazatetracyclo[7.3.1.17,11.01,6]tetradec-3-ene-5,9,12,13,14-pentol

C11H17N3O8 (319.1016)

(2S)-N-(4-chloro-2-methylphenyl)-2-(4-methoxyphenoxy)propanamide

C17H18ClNO3 (319.0975)

(2S)-2-(1,3-benzoxazol-2-ylsulfanyl)-N-(1,3-thiazol-2-yl)butanamide

C14H13N3O2S2 (319.0449)

N-(2,4-Dichloro-5-(2-hydroxyethoxy)phenoxycarbonyl)tetrahydropyrrole

C13H15Cl2NO4 (319.0378)

4-(3,5-Dichloro-4-hydroxyphenylimino)tetralin-1-one

C16H11Cl2NO2 (319.0167)

Benzamil

C13H14ClN7O (319.0948)

Glu-Asp-Gly

C11H17N3O8 (319.1016)

Ro 67-7476

C17H18FNO2S (319.1042)

Ro 67-7476 is a potent positive allosteric modulator of mGluR1 and potentiates glutamate-induced calcium release in HEK293 cells expressing rat mGluR1a with an EC50 of 60.1 nM[1][2]. Ro 67-7476 is a potent P-ERK1/2 agonist?and activates ERK1/2 phosphorylation in the absence of exogenously added glutamate (EC50=163.3 nM)[3].